Brian T Carley's Insider Trades & SAST Disclosures
Brian T Carley's most recent trade in Medpace Holdings Inc was a trade of 1,224 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 16, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brian T Carley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medpace Holdings Inc | Brian T Carley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 1,224 | 1,224 | - | - | Stock Option (Right to Buy) | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 63 | 26,095 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 63 | 186 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.62 per share. | 24 Feb 2025 | 8,127 | 30,035 (0%) | 0% | 42.6 | 346,373 | Common Stock |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 8,127 | 0 | - | - | Stock Option (Right to Buy) | |
| Medpace Holdings Inc | Brian T Carley | Director | Sale of securities on an exchange or to another person at price $ 345.59 per share. | 24 Feb 2025 | 4,003 | 26,032 (0%) | 0% | 345.6 | 1,383,397 | Common Stock |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 78 | 21,908 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 78 | 0 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Brian T Carley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2024 | 249 | 249 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 78 | 21,830 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 78 | 78 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 78 | 21,752 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 78 | 156 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Brian T Carley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 953 | 953 | - | - | Stock Option (Right to Buy) | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 79 | 21,674 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 79 | 234 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | T Brian Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.44 per share. | 20 Feb 2024 | 13,782 | 21,595 (0%) | 0% | 26.4 | 364,396 | Common Stock |
| Medpace Holdings Inc | T Brian Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 13,782 | 0 | - | - | Stock Option (Right to Buy) | |
| Medpace Holdings Inc | T Brian Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 103 | 7,813 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Carley T Brian | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 103 | 0 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | T Brian Carley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 313 | 313 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 103 | 7,607 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 103 | 206 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 7,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.00 per share. | 15 Jun 2023 | 7,400 | 7,504 (0%) | 0% | 23 | 170,200 | Common Stock |
| Medpace Holdings Inc | Brian T Carley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 1,769 | 1,769 | - | - | Stock Option (Right to Buy) | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 104 | 104 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 104 | 309 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Brian T Carley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 413 | 413 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Brian T Carley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 1,903 | 1,903 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Medpace Holdings Inc | Brian T Carley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,822 | 1,822 | - | - | STOCK OPTION (RIGHT TO BUY) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges